DNA Link Inc (127120) — Cash Flow-to-Debt Ratio
DNA Link Inc (127120) has a Cash Flow-to-Debt Ratio of -0.10x as of March 2026, meaning its operating cash flow of ₩-5.37 Billion could theoretically repay 0% of its total liabilities (₩53.95 Billion) in one year. See financial agility of DNA Link Inc to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
DNA Link Inc Cash Flow-to-Debt Ratio (2011–2025)
Historical debt coverage capacity for DNA Link Inc across 14 annual periods. For the full cash flow conversion analysis, see DNA Link Inc operating cash flow efficiency.
Annual Cash Flow-to-Debt Ratio for DNA Link Inc (2011–2025)
Year-by-year debt coverage analysis for DNA Link Inc. Check earnings quality score of DNA Link Inc to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.17x | ₩-9.39 Billion | ₩54.44 Billion | ▲ +25.4% |
| 2024 | -0.23x | ₩-6.78 Billion | ₩29.36 Billion | ▲ +42.7% |
| 2023 | -0.40x | ₩-5.03 Billion | ₩12.48 Billion | ▼ -791.4% |
| 2022 | 0.06x | ₩910.27 Million | ₩15.62 Billion | ▲ +107.5% |
| 2021 | -0.78x | ₩-6.43 Billion | ₩8.25 Billion | ▼ -1370.3% |
| 2020 | 0.06x | ₩849.38 Million | ₩13.84 Billion | ▲ +176.7% |
| 2019 | -0.08x | ₩-1.30 Billion | ₩16.24 Billion | ▲ +22.8% |
| 2018 | -0.10x | ₩-1.60 Billion | ₩15.46 Billion | ▲ +94.1% |
| 2017 | -1.77x | ₩-2.49 Billion | ₩1.41 Billion | ▼ -1026.6% |
| 2016 | -0.16x | ₩-3.77 Billion | ₩24.04 Billion | ▲ +9.5% |
| 2015 | -0.17x | ₩-3.73 Billion | ₩21.53 Billion | ▼ -1442.2% |
| 2014 | -0.01x | ₩-143.14 Million | ₩12.74 Billion | ▲ +82.3% |
| 2012 | -0.06x | ₩-783.00 Million | ₩12.33 Billion | ▲ +76.7% |
| 2011 | -0.27x | ₩-2.44 Billion | ₩8.97 Billion | — |